The results of this study I just reviewed are astounding but seem to be unheard and unrecognized.
CBD safely prevents graft-vs-host disease (GVHD) in kidney transplantation. Graft vs host disease occurs when immune cells from the transplanted kidney attack the person who got the transplant. It’s common because of immune suppression.
CBD was safely administered to 48 transplant men and women with the standard immune suppression prophylaxis. 150 mg of CBD in olive oil was given twice daily, starting 7 days before transplantation until day 30.
No severe adverse events occurred with CBD. Compared to control subjects, the risk of acute GVHD by day 100 among subjects given CBD was reduced 70%.
Remarkably, none of the patients developed acute GVHD while consuming CBD.
Cannabidiol prophylaxis is a safe and promising strategy to reduce the incidence of acute GVHD. Cannabidiol for the Prevention of Graft-Versus-Host-Disease. Biol Blood Marrow Transplant. 2015 Oct;21(10):1770-5.
Bottom line: CBD is effective in transplantation, an extreme form of immune suppression with a perfect safety profile. Cannabidiol cannot be beat for preserving health and preventing disease.